Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

NCT05929495 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT05929495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05929495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
Lead sponsor
University of Milano Bicocca
Phase
Phase 2
Overall status
Recruiting
Start date
February 12, 2024
Completion date
January 1, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, idh-wildtype, malignancies, metformin